Cargando…
High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
Spasticity is a common disabling disorder in adult subjects suffering from stroke, brain injury, multiple sclerosis (MS) and spinal cord injury (SCI). Spasticity may be a disabling symptom in people during rehabilitation and botulinum toxin type A (BTX-A) has become the first-line therapy for the lo...
Autores principales: | Intiso, Domenico, Simone, Valentina, Bartolo, Michelangelo, Santamato, Andrea, Ranieri, Maurizio, Gatta, Maria Teresa, Di Rienzo, Filomena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291232/ https://www.ncbi.nlm.nih.gov/pubmed/32397674 http://dx.doi.org/10.3390/toxins12050315 |
Ejemplares similares
-
Botulinum Toxin—A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke
por: Intiso, Domenico, et al.
Publicado: (2023) -
Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation
por: Intiso, Domenico, et al.
Publicado: (2015) -
Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy
por: Intiso, Domenico, et al.
Publicado: (2020) -
Therapeutic Use of Botulinum Toxin in
Neurorehabilitation
por: Intiso, Domenico
Publicado: (2012) -
Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review
por: Intiso, Domenico, et al.
Publicado: (2022)